MyCEI Login


Caring for Transgender and Gender Expansive People who Use Drugs


Published Date: 05/04/2023

Expiration Date: 03/28/2026

CE Credit: CME:1CNE: 1


Transgender and gender expansive people have a significantly elevated prevalence of substance use disorder diagnosis and are at increased risk for developing mental health problems relative to their cisgender peers. Despite their elevated need for care, transgender and gender expansive people face barriers to care. This activity is designed to increase New York State medical providers’ knowledge of the specific needs of transgender and gender expansive people who use drugs, as well as what barriers to receiving substance us treatment exist for transgender and gender expansive people and how to overcome them.


Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.?


Noelle M Javier ,MD

Noelle Marie Javier, MD is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, Brookdale Department of Geriatrics and Palliative Medicine in New York City. She is a graduate of the University of the Philippines College of Medicine Class of 2002. She finished her residency in Internal Medicine at both Long Island College Hospital, Brooklyn, New York and Jersey City Medical Center, Jersey City, New Jersey. She completed her two-year post-graduate fellowship training in both Geriatric Medicine and Hospice and Palliative Medicine at the University of Michigan Ann Arbor in 2009. She then joined the faculty at the Warren Alpert School of Medicine at Brown University in Providence, Rhode Island before being recruited by the Mount Sinai Health System. In her current capacity as a clinician, educator, and scholar at Mount Sinai, much of her time is spent conducting inpatient consultative service for both subspecialties as well as assistance with the hospital medicine teams. Apart from her clinical duties, she has had opportunities to conduct research, publish, and present at local, regional, national, and international conferences such as the GLMA Annual Conference, American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), and the International Congress in Palliative Care (ICPC). Her areas of scholarly interest include wound care, pain management, medical education, palliative care in the nursing home, rehabilitation in palliative care, pediatric palliative care, and inclusive and affirming geriatric and palliative care for the LGBTQ population.

Learning Objectives

  • Describe the epidemiology and history of drug use among transgender and gender expansive populations.
  • Explain common barriers to substance use treatment for transgender and gender expansive people who use drugs.
  • Describe barriers and ways to overcome them when delivering clinical care to transgender and gender expansive people who use drugs.
  • Identify best practices to establish and implement supportive models of care for transgender and gender expansive people who use drugs.

Continuing Education Credit Information